These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7827184)
21. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Yung S; Thomas GJ; Stylianou E; Williams JD; Coles GA; Davies M Am J Pathol; 1995 Feb; 146(2):520-9. PubMed ID: 7856761 [TBL] [Abstract][Full Text] [Related]
22. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells. Breborowicz A; Rodela H; Karoń J; Martis L; Oreopoulos DG Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217 [TBL] [Abstract][Full Text] [Related]
23. The biology of the mesothelium during peritoneal dialysis. Hjelle JT; Miller-Hjelle MA; Dobbie JW Perit Dial Int; 1995; 15(7 Suppl):S13-22; discussion S22-3. PubMed ID: 8555322 [TBL] [Abstract][Full Text] [Related]
24. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736 [TBL] [Abstract][Full Text] [Related]
25. [Effects of growth factors on proliferation of cultured human peritoneal mesothelial cells]. Iwamoto I; Imada A Nihon Jinzo Gakkai Shi; 1992 Nov; 34(11):1201-8. PubMed ID: 1294774 [TBL] [Abstract][Full Text] [Related]
27. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040 [TBL] [Abstract][Full Text] [Related]
28. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
29. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497 [TBL] [Abstract][Full Text] [Related]
30. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031 [TBL] [Abstract][Full Text] [Related]
31. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Krediet RT Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764 [TBL] [Abstract][Full Text] [Related]
32. Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: role of interleukin-1alpha. Mandl-Weber S; Haslinger B; Lederer SR; Sitter T Am J Kidney Dis; 2001 Apr; 37(4):815-9. PubMed ID: 11273882 [TBL] [Abstract][Full Text] [Related]
33. A rapid high performance liquid chromatographic method for the analysis of choline in human plasma and peritoneal dialysis effluent: application in the assessment of choline loss in continuous ambulatory peritoneal dialysis. Webb LE; Pavlina TM; Hjelle JT Clin Biochem; 1993 Jun; 26(3):173-7. PubMed ID: 8330385 [TBL] [Abstract][Full Text] [Related]
35. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid. Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332 [TBL] [Abstract][Full Text] [Related]
36. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients. Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648 [TBL] [Abstract][Full Text] [Related]
37. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients. Ziegler C; Torchia M; Grahame GR; Ferguson IA Perit Dial Int; 1989; 9(1):47-9. PubMed ID: 2488180 [TBL] [Abstract][Full Text] [Related]
38. Sulodexide modulates the dialysate effect on the peritoneal mesothelium. Misian M; Baum E; Breborowicz A J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203941 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. van Bronswijk H; Verbrugh HA; Bos HJ; Heezius EC; Oe PL; van der Meulen J; Verhoef J Perit Dial Int; 1989; 9(3):197-202. PubMed ID: 2488365 [TBL] [Abstract][Full Text] [Related]